300288 Guiyang Longmaster Information & Technology
- 13.34
- +0.54+4.22%
Guiyang Longmaster Information & Technology News
Langma Information (300288.SZ): The decline in results for the first quarter of 2024 was mainly due to a decrease in revenue from the medical information service and mobile resale business, the two major businesses
Gelonghui, April 24 | Longma Information (300288.SZ) said on the investor interaction platform that the company is operating normally, and the decline in performance in the first quarter of 2024 was mainly due to a decrease in revenue from the medical information service and mobile resale business, the wholly-owned subsidiary Guangzhou Qisheng Information Technology Co., Ltd. (39 Health Network). The decline in revenue from the medical information service business operated by Qisheng Information Technology Co., Ltd. (39 Health Network) was mainly due to a large amount of high-quality medical information content from Qisheng Information Technology Co., Ltd. (39 Health Network), which was not used for sales monetization, but for its own medical artificial intelligence learning and training; the holding subsidiary Guiyang Langma Communication Technology Co., Ltd.
Langma Information (300288.SZ) released its 2023 annual results, net profit of 774.571 million yuan, an increase of 10.19% over the previous year
Langma Information (300288.SZ) released its 2023 annual report. The company achieved operating income of 4 during the reporting period...
Langma Information (300288.SZ): “39AI General Practitioner” products have not yet been charged to customers
Gelonghui, April 18 | Longma Information (300288.SZ) said on the investor interactive platform that the company's “39AI General Practitioner” product has not yet been charged to customers, and the product currently does not bring direct revenue to the company. Please pay attention to the relevant announcements issued by the company in the future.
Langma Information (300288.SZ): “39AI General Practitioner” products have not brought direct revenue to the company
Gelonghui, April 9 | Longma Information (300288.SZ) said on the investor interactive platform that the company's “39AI General Practitioner” products have not brought direct revenue to the company. Please pay attention to the company's subsequent announcements regarding product operation.
Langma Information (300288.SZ): The self-developed “Rayaxin” medical module is currently mainly used in blood sugar meter products
Gelonghui, April 3 | Longma Information (300288.SZ) said on the investor interactive platform that the “Rayaxin” medical module independently developed by the company is currently mainly used in blood sugar meter products, but this business has contributed little to the company's business performance.
Langma Information (300288.SZ): There is currently no business cooperation with Xiaomi in the field of medical artificial intelligence
Gelonghui, March 26 | Longma Information (300288.SZ) said on the investor interactive platform that the company has not currently developed business cooperation with Xiaomi in the field of medical artificial intelligence.
Langma Information (300288.SZ): We have a business partnership with Huawei in the health business sector
Gelonghui March 25 | Longma Information (300288.SZ) said on the investor interactive platform that currently the company and Huawei have business cooperation in the health business sector, mainly the “39 Health” fast app service launched on its mobile phones and Android phones.
Langma Information (300288.SZ) has not yet carried out large-scale marketing of “39AI General Practitioners”
Gelonghui, March 18 | Longma Information (300288.SZ) said on the investor interactive platform that the company has not yet carried out large-scale marketing of “39AI General Practitioners”. At this stage, the focus is on improving and upgrading the product based on user feedback, and introducing more and better practical functions to meet user needs in subsequent iterations.
Langma Information (300288.SZ) and related personnel received a warning letter from the Guizhou Securities Regulatory Bureau
Langma Information (300288.SZ) announced that the company received China Securities Regulatory Administration on March 14, 2024...
A-share changes丨Longma Information once surged 13% 39AI General Practitioner Content Generation Algorithm Filing Passed
Glonghui, Feb. 20 | Longma Information (300288.SZ) surged 13% during the intraday period, up 13.28 yuan. It has risen more than 30% in the past 3 days to almost recover from the previous decline, with a total market value of 4.25 billion yuan. According to the news, on February 18, the State Internet Information Office issued an announcement on the fourth batch of in-depth synthesis service algorithm filing information. The company's “39 Health and Medical Content Generation Algorithms” passed the Deep Synthesis Service Algorithm Filing. Furthermore, at the beginning of this month, the company and its holding subsidiaries were re-certified as high-tech enterprises.
Langma Information (300288.SZ): “39AI General Practitioner” Content Generation Algorithm Filing Passed
Gelonghui, Feb. 19, 丨 Langma Information (300288.SZ) announced that on February 18, 2024, the State Internet Information Office issued an announcement on the fourth batch of in-depth synthesis service algorithm filing information. Guiyang Longma Information Technology Co., Ltd. “39 Health and Medical Content Generation Algorithms” passed the Deep Synthesis Service Algorithm Filing.
Langma Information (300288.SZ): As of January 19, 2024, the number of shareholders in the company was 45,612
Gelonghui January 29 | Longma Information (300288.SZ) said on the investor interactive platform that as of January 19, 2024, the number of shareholders of the company was 45,612.
Langma Information (300288.SZ): The audio processing patent applied for is mainly optimization and innovation based on the company's existing relevant technology
Gelonghui, January 9 | Langma Information (300288.SZ) said on the investor interactive platform that the audio processing patents applied for by the company are mainly optimization and innovation based on the company's existing relevant technology, and have not yet been applied in the field of artificial intelligence.
Game stocks have plummeted. How much impact will the policy have? Industry insiders: Influential but no need to overreact
Many industry insiders believe that if some provisions of the “Administrative Measures” are strictly implemented, it may indeed have an impact on the operation of game products, but the current overall market reaction is a bit excessive.
Langma Information (300288.SZ): The company's “39AI General Practitioner” product application direction is for medical questions and answers, health consultation, and clinical diagnosis to assist doctors in clinical diagnosis
Glonghui, December 11|Langma Information (300288.SZ) stated on the investor interactive platform that the application direction of the company's “39AI General Practitioner” product is for medical questions and answers, health consultation, and clinical diagnosis support for physicians. The scope of application includes general users and doctor users. The company mainly developed “39AI General Practitioner” based on the massive medical and health data resources accumulated over many years of Internet medical business. It is not clear whether other companies are developing the same or similar models.
Langma Information (300288.SZ): As of November 30, 2023, the number of shareholders of the company is 52583
Glonghui December 5 | Langma Information (300288.SZ) stated on the investor interactive platform that as of November 30, 2023, the number of shareholders in the company was 5,2583.
Changes in A-shares | Langma Information once plummeted by more than 11%, clarifying that 39AI general practitioners have not yet actually been applied
Glonghui, November 23 | Langma Information (300288.SZ), which hit a new high yesterday, once plummeted by more than 11% and is now reported at 19.05 yuan, with a total market value of 6.4 billion yuan. The company announced yesterday evening that the “39AI General Practitioner” product cannot replace doctors in carrying out medical services. Currently, the product has not been put into actual use. It also did not bring direct revenue to the company and will not affect the company's business performance in 2023.
Langma Information (300288.SZ): There are currently no plans to invest in the paid short video business
Glonghui November 22|Langma Information (300288.SZ) stated on the investor interactive platform that Guizhou Langshi Media Technology Co., Ltd. was cancelled in 2016, and the company currently has no plans to invest in the paid short video business.
Changes in A-shares | Langma Information's 20CM rise and stop, 39AI general practitioner model filing approved
Gelonghui, November 21 | Longma Information (300288.SZ) has closed the market. Currently, the blocked order amount is close to 600 million yuan, reaching a four-month high of 19.27 yuan, with a total market value of 6.66 billion yuan. According to the news, the company announced yesterday evening that the “39AI General Practitioner” large-scale model has been approved, and that the closed beta will be open to users in due course. This means that the company has achieved phased results in research and development in the field of medical artificial intelligence, and it is important to maintain the company's continuous competitiveness in business and enhance the company's core competitiveness.
Langma Information: “39AI General Practitioner” Big Model Filing Approved
Gelonghui November 20 | Langma Information Notice, “39AI General Practitioner” Big Model Filing Approved, and Closed Beta Will Be Open to Users in a Timely Period of Time.
Analysis
Price Target
No Data
